Patients with scleroderma have reduced levels of Cathepsin L

Much of the research on scleroderma, a connective tissue disease that causes scarring, or fibrosis, has focused on the increased number of proteins promoting fibrosis in these patients. A Medical University of South Carolina (MUSC) research team took a different tact and measured the levels of an antifibrotic protein, Cathepsin L, in these patients.

Related Keywords

Carol Feghali Bostwick ,Joe Mouawad ,Kitty Trask Holt ,Emily Henderson ,University Of South Carolina ,Scleroderma Research ,Drug Administration ,National Scleroderma Foundation ,Medical University ,South Carolina ,Kitty Trask Holt Endowed Chair ,Phd Student ,Fibrosis ,Scleroderma ,Drugs ,Education ,Fibroblast ,Hospital ,Lungs ,Medicine ,Mh ,Protein ,Research ,Heumatology ,